Quality Comes First COUNTRIES CONTACT US EN ABOUT US KEY AREAS INNOVATION & RESEARCH PARTNERING RESPONSIBILITY NEWS & MORE CAREERS Sorry, your browser doesn't support embedded videos. About Us HOME ABOUT US Our Group "As one of the oldest pharmaceutical companies in the world, we take pride in our heritage with a keen eye for the future defined by an unwavering commitment for patient cause." Elcin Barker Ergun MENARINI GROUP CEO High quality therapeutics and diagnostics solutions for patients, ethics as our underlying principle, dedication to innovation and advancement, strong people centricity and environmental sustainability. These five pillars form the foundation of the Menarini Group, an Italian pharmaceutical company with 135 years of history. Founded in 1886 in Naples under the name of Farmacia Internazionale, in 1915 Menarini moved to Florence where the Group’s headquarters are still located today. The Menarini Group is present in 140 countries around the world. Its companies span from Europe to Asia, to Africa and the Middle East, to Central America and to the United States where with the acquisition of Stemline Therapeutics, a NASDAQ-listed biopharmaceutical company, the company marked its entry into the US oncology market. Thanks to the valuable contribution of over 17,000 employees, every year almost 600 million packs of drugs are produced at the Group's 18 manufacturing sites including a biotech plant for the manufacturing of monoclonal antibodies that also serves external clients. Our drugs are distributed across 6 continents for the treatment of pathologies in cardiology, pneumology, inflammation and gastroenterology. Menarini invests in the future and guarantees drug availability in the present for the improvement of patient health and well-being. In its 10 Research & Development centers, Menarini’s main focus is dedicated to therapeutic areas with unresolved pathologies, such as oncology and anti-infectives (AMR), where increasing treatment options is fundamental to helping those in need. The Group's pipeline concentrates on innovative drugs and technologies including both small molecule and biologics for hematologic and solid tumors for greater personalized solutions. The Group has also invested in diagnostics to develop instruments with high speed and precision for diagnoses in various fields such as clinical chemistry, diabetes, immunology, hematology, histology and point-of-care. In addition, Menarini is developing advanced technologies for the analysis of rare tumor cells with single cell precision. From research to manufacturing, from distribution to scientific information, Menarini's goal is to achieve excellence. Governance Board of Directors Executive Team Consolidated Turnover Company Profile DOWNLOAD PDF Our history Discover our milestones since 1886: the origins, the international expansion step by step and the recent acquisitions. READ MORE Our values Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history. READ MORE NEWS READ ALL NEWS 2021 - 11 - 4 Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia Florence (Italy) November 4th, 2021 – The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for... READ MORE 2021 - 10 - 20 Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer Florence, Italy and Boston, Mass., October 20, 2021 – the Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the... READ MORE 2021 - 10 - 19 Serie A: the Volpi Rosse Menarini are ready to meet the challenge On 23 October, the first wheelchair basketball team in Tuscany will take part in the Serie A of the National Championship of the FIPIC (Italian Wheelchair Basketball Federation). The... READ MORE SEARCH MENARINI IN THE WORLD Search your country 92 23 4 52 17 3 MENARINI PILLS OF ART Discover our initiative which confirms the company’s affiliation with art. READ MORE FONDAZIONE INTERNAZIONALE MENARINI a meeting point for all friends with common ideals towards the progress of sciences for the benefit of mankind. sergio gorini, foundation’s first president READ MORE Contact Us Terms and conditions Data Privacy Sitemap Pharmacovigilance Cookie Setting Follow Us A.Menarini Industrie Farmaceutiche Riunite S.r.l. VAT number and registration number in the Company House: 00395270481 Office of the Companies House: Florence Share Capital: € 150.000.0000 I.V. © 2021 The Menarini Group - All rights reserved SHARE ON Facebook Twitter SCROLL TO TOP Our website uses cookies, including third party cookies. In addition to Strictly necessary cookies that are essential to browse the website, the site features Functional cookies that ensure you make the most of your browsing experience, Performance cookies, that perform aggregate statistics on the website usage, as well as Targeting cookies that automatically tailor on-line ads on the preferences you expressed while browsing this or other websites. Should you wish to receive more information click on the Cookie Policy. To inhibit Functional cookies, Performance cookies, Targeting cookies and/or cookies of specific third parties click on MORE OPTIONS. By clicking I ACCEPT you will be accepting all the mentioned types of cookies. I ACCEPT MORE OPTIONS